| |
Investigator
|
Source
|
Title |
|
| Yuri Bushkin, Ph.D. |
NIH |
CD8+ T-Cell Response in Resistance to Tuberculosis |
|
NIH |
HLA-Releasing Metalloproteinase In Allograft Rejection
|
| Karl Drlica, Ph.D. |
NIH |
DNA Gyrase and Quinolone Resistance in Tuberculosis |
|
Bayer |
Comparison of Levofloxacin and Moxifloxacin Action against S. pneumoniae
|
| David Dubnau, Ph.D. |
NIH |
The Genetic Competence Apparatus of Bacillus Subtilis |
|
NIH |
Regulation of Genetic Compentence in Bacillus Subtilis
|
| Maria Gennaro, M.D. |
NIH |
Immunological Diagnosis of Tuberculosis
|
| Alexander Goldfarb, Ph.D. |
NIH |
Structure and Function of RNA Polymerase in E. Coli
|
| Gilla Kaplan, Ph.D. |
NIH |
Host and Pathogen Determinants of M. tuberculosis Latency |
|
NIH |
Regulation of Early Cytokine Responses to TB Infection |
|
NIH |
Vaccination Ð Induced Immune Correlate of Protection |
|
Heiser |
Immune Correlates of M. tuberculosis Latency
|
| Fred R. Kramer, Ph.D. |
NIH |
Molecular Beacons For Retroviral Diagnostics
|
| Barry Kreiswrith, Ph.D. |
NYSDH |
Finger Printing Lab |
|
NYC |
NYC TB Fingerprinting Project |
|
NJDHSS |
Antimicrobial Resistance Project |
|
RBTL |
Develop M. tuberculosis phage as an Adjunct Therapeutic Approach to Treat Tuberculosis |
|
NYCT |
Developing Fluoroquinolone Resistant in Naïve Population |
|
Merck |
Genotyping S. epidermidis |
|
PPI |
Constructing Drug Target Mutants and the Testing of Novel Compounds
|
| Leonard Mindich, Ph.D. |
NIH |
Assembly and Recombination of dsRNA Bacteriphage Phi 8 |
|
NIH |
Packaging of the Segmented Genome of Bacteriophage phi 6
|
| Vajay Pancholi, Ph.D. |
NIH |
Role of Surface Dehydrogenase in Streptoccal Infection
|
David Perlin, Ph.D.
(co-PI Fred R. Kramer, Ph.D.) |
DOE |
Rapid Detection of Bioterrorism Agents |
|
NIH |
Rapid Evaluation of Drug Resistance in Pathogenic Fungi |
|
(co-PI Barry Kreiswirth, Ph.D.) |
NYCT |
Development of Rapid Diagnostic Probes for Bioterrorism Agents |
|
NIH |
Energy Coupling by the Yeast Plasma Membrane-ATPase |
|
Merck |
Isolation of Caspofungin-resistant Aspergillus Fumigatus Mutants and Development of FKS DNA Sequence Database for Clinical Isolates |
|
Pfizer |
Development of Funal H+-ATPase as a Drug Discovery Target
|
| Richard Pine, Ph.D. |
NIH |
Host Response to TB & AIDS (subcontract from NYU) |
|
NIH |
Functional Genomics of Interferon for Tuberculosis
|
| Abraham Pinter, Ph.D. |
NIH |
Antigenic Properties of the V1/V2 Domain of HIV-1 |
|
NIH |
Novel HIV-Neutralizing Human Mabs for Transgenic Mice |
|
NIH |
Cross-clade & Intra-Clade Conserved V3 Neutralization Targets |
|
DYO |
Evaluation of Mutations Responsible for Genetic Diseases in Humans
|
| Issar Smith, Ph.D. |
NIH |
M. Tuberculosis Survival of Growth In Vivo |
|
NIH |
Studies of M. Tuberculosis Survival in Animal Models |
| (co-PI Sanjay Tyagi, Ph.D.) |
NIH |
M. Tuberculosis and Host Gene Expression
|
| Sanjay Tyagi, Ph.D. |
NIH |
Detecting mRNAs in Living Cells With Molecular Beacons |
| DYO |
Dor Yeshorim Organization DY-200 |
| NIH |
National Institute of Health |
| NJCST |
New Jersey Commission of Science and Technology |
| NJDHSS |
New Jersey Department of Health & Senior Services |
| NYC |
New York City Department of Health |
| NYCT |
New York Community Trust |
| NYSDH |
New York State Department of Health |
| NYU |
New York University |
| PPI |
Pyro Pharmaceutical, Inc. |
| RBTL |
Regma Bio Technologies Ltd |
| SF |
Sequella Foundation |
| SWHRF |
Stony Wold Herbert Research Fund |
| USADD |
Untied States Army Department of Defense |
Funding Agencies Abbreviations